Autoimmune encephalomyelitis in NOD mice is not initially a progressive multiple sclerosis model
Abstract Objective Despite progress in treating relapsing multiple sclerosis (MS), effective inhibition of nonrelapsing progressive MS is an urgent, unmet, clinical need. Animal models of MS, such as experimental autoimmune encephalomyelitis (EAE), provide valuable tools to examine the mechanisms co...
Main Authors: | David Baker, Erik Nutma, Helen O'Shea, Anne Cooke, Jacqueline M. Orian, Sandra Amor |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2019-08-01
|
Series: | Annals of Clinical and Translational Neurology |
Online Access: | https://doi.org/10.1002/acn3.792 |
Similar Items
-
Initiation of Autoimmunity in Experimental Autoimmune Encephalomyelitis
by: Isaksson, Magnus
Published: (2012) -
Systemic Acrolein Elevations in Mice With Experimental Autoimmune Encephalomyelitis and Patients With Multiple Sclerosis
by: Melissa Tully, et al.
Published: (2018-06-01) -
Nearby Construction Impedes the Progression to Overt Autoimmune Diabetes in NOD Mice
by: Erin E. Hillhouse, et al.
Published: (2013-01-01) -
Orexin/hypocretinin in multiple sclerosis and experimental autoimmune encephalomyelitis
by: Jean Pierre Pallais, et al.
Published: (2020-01-01) -
Dysregulation of lysophosphatidic acids in multiple sclerosis and autoimmune encephalomyelitis
by: K. Schmitz, et al.
Published: (2017-06-01)